Molecular detection of a polymorphism in the p53 codon 72 gene and its association with prostate cancer

The role of the current study in detecting polymorphisms in the gene P53codon72, a gene that has morphological polymorphism and has an important role in the incidence of diseases, especially cancers such as prostate cancer, samples for the study were collected from 50 patients with prostate cancer from the auditors of the Imam Hussein Center for Cancer and Diseases Blood in Al-Hussein, peace be upon him, Teaching Hospital - Holy Karbala Governorate - Iraq After diagnosis by a specialist surgeon and 50 phenotypically healthy individuals as a control group, the (DNA) was extracted from the blood of both healthy and all patients study groups, and molecular detection of polymorphism of nucleotides was performed in Genes of the study using PCR-RFLP Molecular detection results in P53codon72 The results showed that there were highly significant differences between the genotype (Pro-Pro) and between the infected and healthy groups as well as the genotype (Arg-Arg), while there was no significant relationship between the genotype (Arg-Pro) and between the infected and healthy groups. The results also showed highly significant differences between the three genotypes (Arg/ Arg, Aro/Pro, Pro/Pro) and between the two groups sick and healthy.

• Publication year

  2022

• Venue

  International Journal of Health Sciences

• Publication date

  2022-06-21

• Fields of study

  Not labeled

• Identifiers
  DOI 10.53730/ijhs.v6ns4.9388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinicopathological profile of clear cell renal cell carcinoma

  2022cited by this paper
• The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

  2021cited by this paper
• Endocrinology of the Aging Prostate: Current Concepts

  2021cited by this paper
• DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

  2021cited by this paper
• Molecular detection of Wolbachia endosymbiont in reptiles and their ectoparasites

  2021cited by this paper
• Arbutin as a Skin Depigmenting Agent with Antimelanogenic and Antioxidant Properties

  2021cited by this paper
• Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021.

  2021cited by this paper
• Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis

  2021cited by this paper
• Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment

  2021cited by this paper
• Evaluation of TP53 codon 72 polymorphism in esophageal cancer susceptibility in Eastern Anatolia Region of Turkey

  2021cited by this paper
• The role of metformin, statins and diet in men on active surveillance for prostate cancer

  2021cited by this paper
• The hyperfunction theory: an emerging paradigm for the biology of aging

  2021cited by this paper
• Health and treatment of diabetes mellitus

  2021cited by this paper
• Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women

  2021cited by this paper
• The effect of montelukast on CD14 gene expression in asthmatic patient in Kerbala

  2020cited by this paper
• The relationship between smoking and Urokinase gene 3’-UTR T/C expression on occurrence of bladder cancer

  2020cited by this paper
• Association of urokinase and Vitamin D receptor genes SNPs and urolithiasis in an Iraqi population

  2020cited by this paper
• Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.

  2019cited by this paper
• Molecular Detection of MTHFR gene Polymorphisms in Transitional Urinary Bladder Cancer Patients

  2019cited by this paper
• Association between tumor necrosis factor alpha gene polymorphisms and multiple myeloma risk: an updated meta-analysis

  2018cited by this paper
• GSTM1 and GSTT1 Polymorphisms and Susceptibility to Prostate Cancer: A Case-Control Study of the Algerian Population

  2018cited by this paper
• Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India.

  2011cited by this paper
• The p53 codon 72 polymorphism and association to prostate cancer in Iranian patients

  2011cited by this paper
• P53 Codon 72 (Arg72Pro) Polymorphism and Prostate Cancer Risk: Association between Disease Onset and Proline Genotype

  2011cited by this paper
• ) Relationship between

  2009cited by this paper
• P53 Codon 72 Polymorphism의 위암의 예민도

  2005cited by this paper
• p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.

  2004cited by this paper
• THE CLASSIFICATION OF TUMORS

  1916cited by this paper

• No citing papers are available for this paper.